Figures
Abstract
Methicillin-resistant Staphylococci (MRS) cause infections at various sites and exhibit multidrug resistance. Despite their importance in veterinary medicine, only little is known about Staphylococcus spp. colonizing and infecting cats. Therefore, in this study, we aimed to isolate and identify Staphylococcus spp. colonizing hospitalized and non-hospitalized domestic cats and analyze their antimicrobial resistance profiles, genetic diversity, and risk factors associated with MRS colonization. A total of 218 oral and axillary swabs were obtained from 109 cats, including 77 non-hospitalized and 32 hospitalized cats. After plating on selective media, the isolates were identified via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and rpoB and 16S rRNA gene sequencing. Subsequently, antimicrobial sensitivity of the strains was assessed, and they were screened for mecA gene. Methicillin-resistant S. haemolyticus (MRSH) isolates were subjected to multilocus sequence typing, whereas methicillin-resistant S. pseudintermedius (MRSP) and S. felis isolates were subjected to whole genome sequencing. S. felis was most commonly isolated from non-hospitalized cats (28.1%), whereas S. pseudintermedius and MRS were commonly isolated from hospitalized cats (25%). MRSH isolates from hospitalized animals were classified as ST3. The identified MRSP strains belonged to two well-known sequence types, ST551 and ST71. Moreover, antimicrobial use (p = 0.0001), hospitalization (p = 0.0141), and comorbidities (p = 0.002) were associated with increased MRS prevalence in cats.
Citation: Souza TGVd, Santana JA, Claudino MMS, Pereira ST, Xavier RGC, do Amarante VS, et al. (2024) Occurrence, genetic diversity, and antimicrobial resistance of methicillin-resistant Staphylococcus spp. in hospitalized and non-hospitalized cats in Brazil. PLoS ONE 19(10): e0309711. https://doi.org/10.1371/journal.pone.0309711
Editor: Baochuan Lin, Defense Threat Reduction Agency, UNITED STATES OF AMERICA
Received: March 28, 2024; Accepted: August 16, 2024; Published: October 3, 2024
Copyright: © 2024 Souza et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting information files.
Funding: This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico, by Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG RED-00132-16 and APQ-00524-17) and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Staphylococcus spp. colonize various hosts and play crucial roles in the oral and skin microbiota of humans and animals [1, 2]. Among more than 75 species identified to date, S. aureus and S. pseudintermedius cause infections at different sites, with many methicillin-resistant Staphylococci (MRS) detected worldwide, especially in animals and hospitalized individuals [3–6]. MRS are characterized by beta-lactam resistance with low-affinity penicillin-binding proteins (PBP2a or PBP2). One such protein is encoded by the mecA gene located on a mobile genetic element, known as staphylococcal cassette chromosome mec (SCCmec) [7]. MRS are also resistant to other class antibiotics, such as macrolides, aminoglycosides, tetracyclines, and fluoroquinolones [8, 9].
Among the various MRS observed in veterinary medicine, methicillin-resistant S. pseudintermedius (MRSP) is the most important bacterial agent detected in small animals. MRSP causes hospital outbreaks and severe infections, such as pyoderma, surgical site infections, external otitis, and urinary tract infections [10–13]. Furthermore, these strains act as reservoirs for resistance determinants in other staphylococci, facilitating the spread of multidrug resistance and impacting the efficacy of antimicrobials [10–13]. Many studies have indicated the importance of methicillin-resistant coagulase-negative Staphylococci. Methicillin-resistant S. haemolyticus (MRSH) and S. epidermidis widely infect humans and animals [14–20].
Despite the importance of MRS in veterinary medicine, their roles in the infection and colonization of cats remain unknown. Cats act as carriers of MRSP and are susceptible to MRSP infections [17, 21–23]. However, risk factors associated with MRS colonization of cats remain unknown. Only a few studies have explored the genetic diversity and resistance profiles of these isolates in cats [17, 22–24], with none focused in Brazil.
In this study, we aimed to isolate and identify Staphylococcus spp. colonizing hospitalized and non-hospitalized domestic cats. Additionally, we examined their antimicrobial resistance profiles, genetic relationships, and risk factors associated with MRS colonization.
Material and methods
Sample collection
A cross-sectional study using convenience sampling was conducted among non-hospitalized domestic (n = 77, 70.7%) and hospitalized (n = 32, 29.3%) cats at a veterinary clinic in Belo Horizonte, Minas Gerais (Brazil), totaling 218 oral and axillary swabs from 109 cats. Samples from household cats were collected during visits by the research team, whereas those from hospitalized cats were collected from the inpatients at the MedVet Veterinary Clinic in Belo Horizonte, Brazil.
Swab samples were stored in the Stuart Transport Medium (HiMedia, India) under refrigeration (4 °C) for up to 36 h until processing. For both groups, information on sex, age, outdoor access, interaction with other cats or animals, presence of comorbidities, and use of antimicrobials in the last six months was collected (S1 File). This study was approved by the Ethics Committee on Animal Use of the Federal University of Minas Gerais (protocol 287/2019). Informed consent was obtained from all owners through an online consent form prior to sample collection.
Isolation and identification of Staphylococcus spp.
Swab samples were plated on selective media (Mannitol Salt agar, MS–KASVI, Italy) and incubated at 37 °C for 24 h. Colonies formed were subsequently plated on the brain heart infusion agar (Oxoid, UK) and stored in the brain heart infusion broth (Oxoid) supplemented with 20% glycerol at –20 °C. For matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), each sample was plated on the brain heart infusion agar (Oxoid), as previously described [12, 25]. Then, 1 μL of formic acid (70%) and 1 μL of MALDI-TOF MS matrix, consisting of a saturated solution of α-cyano-4-hydroxycinnamic acid (Bruker Daltonics, Bremen, Germany), were applied to the spot and allowed to air dry. The spectra were acquired using the FlexControl MicroFlex LT mass spectrometer (Bruker Daltonics). Prior to measurement, calibration was performed using a bacterial test standard (Escherichia coli DH5 alpha; Bruker Daltonics). Isolates with MALDI-TOF score < 2.0 were sujected to DNA extraction using the guanidine method to sequence rpoB and 16S rRNA to confirm their identity [26, 27]. Furthermore, isolates belonging to the S. intermedius group (SIG) were subjected to monoplex polymerase chain reaction (PCR) to detect nuc (pse), as previously described [12, 28].
Antimicrobial susceptibility testing
All isolates were subjected to a disk diffusion test as recommended by the M100-Ed31 Clinical and Laboratory Standards Institute guidelines [29]. The following antimicrobials were selected based on previous reports [12, 13]: oxacillin (1 μg), cefoxitin (30 μg), penicillin (10 IU), ciprofloxacin (5 μg), chloramphenicol (30 μg), clindamycin (2 μg), erythromycin (15 μg), gentamicin (10 μg), nitrofurantoin (300 μg), rifampicin (5 μg), sulfamethoxazole-trimethoprim (1.25/23.75 μg), and tetracycline (30 μg) (DME, Brazil). S. aureus ATCC® 25923 was used as a control. Isolates exhibiting resistance to three or more antimicrobial classes were classified as multidrug-resistant (MDR) strains [30].
Detection of mecA
Isolates resistant to oxacillin or cefoxitin in the disk diffusion method were subjected to DNA extraction using guanidium thiocyanate, as previously described [31]. After quantification using the NanoDrop spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA), all isolates were subjected to PCR [32] to detect mecA using the following primers: forward 5´-AAAATCGATGGTAAAGGTTGGC-3´ and reverse 5´AGTTCTGCAGTACCGGATTTGC-3´.
Multilocus sequence typing (MLST) of MRSH isolates
MRSH strains were subjected to MLST, as previously described [14, 33]. Briefly, genomic DNA was extracted using the Wizard Genomic DNA Purification Kit (Promega, EUA), and PCRs was performed as previously described [12, 13]. Sequencing reactions were performed using a BigDye Terminator Cycle Sequencing Kit (Life Technologies) on an ABI 3730XL Genetic Analyzer (Life Technologies). Alleles and sequence types (STs) were analyzed using the PubMLST database for S. haemolyticus (http://pubmlst.org/shaemolyticus/). Phyloviz v 2.0, using the goeBURST algorithm [34, 35], was used to infer the population structure, with clonal complexes (CCs) composed of all strains sharing at least six identical alleles (single-locus variants). A Neighbor-joining tree was generated from concatenated sequences of the seven housekeeping genes using MEGA version X (https://www.megasoftware.net/) with bootstrap analysis with 1000 replicates, and visualized and annotated using iTOL v.4 [14, 33, 36].
Genome sequencing of MRSP and S. felis isolates
Next, three MRSP and six S. felis isolates were subjected to genome sequencing [12, 13, 37]. The strains were incubated on Mueller–Hinton agar at 37 °C for 24 h. Genomic DNA was extracted using Wizard Genomic DNA Purification Kit (Promega, EUA). Genome sequencing was performed using the Illumina HiSeq platform (mid-out 2 × 150 bp cycles), and the raw data were analyzed using FastQC (Babraham Bioinformatics, Cambridge, England), retaining only paired reads with Phred quality of 30 or higher and a minimal size of 50 nucleotides.
The assembly was performed using SPAdes 3.5.0 in the careful mode [38]. GAP filling and polishing were performed using a Pilon [39]. ResFinder 4.1 [40–42] and PlasmidFinder 2.1 [43, 44] were used to identify the determinants of acquired antimicrobial resistance and conjugative plasmid replicons, respectively. SCCmecFinder 1.2 was used for Staphylococcal Cassette Chromosome mec (SCCmec) typing [40, 45]. MLST 2.0 was used to determine sequencing types [40, 41, 46].
The contigs were subjected to single nucleotide polymorphism (SNP) analysis using CSIPhylogeny [47] with a minimal Z-score of 1.96 and a minimal depth at SNP position of 10x. S. pseudintermedius DG072 (accession number SAMN17102122) and S. felis FDAARGOS_1014 (accession number SAMN16357183) were used as references for SNP analysis. Sequenced genomes were subjected to whole-genome MLST (wgMLST) analysis using Cano-wgMLST _BacCompare [48, 49]. MRSP strains from recent studies conducted in the same city were included for genetic comparison purpose [12, 13]. Isolates of S. felis included in the present study were downloaded from the Bacterial and Viral Bioinformatics Resource Center (https://www.bv-brc.org/) and from previous studies [37, 50, 51] (S2 Table in S1 File). All trees were generated using the iTOL online software and midpoint rooting [36].
Statistical analyses
Associations between the isolation of specific Staphylococcus spp, including MRS, MDR, and MRSP, and various factors was evaluated via univariate analysis using Fisher’s exact test. These factors included the origin of the animals (hospitalized vs. non-hospitalized), use of antimicrobials, sex, contact with other animals, outdoor access, and presence of comorbidities. Associations were expressed as odds ratios (ORs) and 95% confidence intervals (CIs), and statistical significance was set at p < 0.05. To conduct statistical analyses for age, the animals were categorized into kittens, adults, and elderly population as described by Santana et al. [13]. All analyses were performed using Stata version 14 (Stata Corp. LLC, USA).
Results
Samples and epidemiological data
A total of 109 cats were sampled, including 51.4% (56/109) females who were mostly adults (average age of 58 months ± 47 months) with outdoor access (34.9%) and interacted with other animals (82.6%; S1 Table in S1 File). Approximately 17.4% exhibited a history of antimicrobial use, primarily of cephalothin (36.8%), ceftriaxone (31.6%), metronidazole (21.1%), and clindamycin (21.1%), in the last six months. Approximately 36.7% of the cats exhibited at least one comorbidity.
Frequency of Staphylococcus spp.
A total of 81 Staphylococcus spp. isolates, including 70.4% (57/81) from non-hospitalized cats and 29.6% (24/81) from hospitalized cats (Table 1), were analyzed in this study. Thirty-one isolates (38.3%) were obtained from the axillary site and 50 (61.7%) from the oral site (Fig 1).
Of the 81 isolates obtained, 65 (80.3%) were identified via MALDI-TOF or PCR for SIG group differentiation. Sixteen isolates (19.7%) were subjected to sequencing of rpoB and 16S rRNA due to their low identity scores in MALDI-TOF MS. S. felis was the most commonly detected species in this study (24.7%; Table 2), followed by S. epidermidis (13.6%), S. pseudintermedius (10%), and S. haemolyticus (8.6%). S. pseudintermedius frequency was higher in hospitalized cats than in the non-hospitalized cats (p = 0.007). S. pseudintermedius was the only representative species of SIG group identified in this study.
Antimicrobial sensitivity
Most Staphylococcus spp. isolates were resistant to penicillin (61.7%; Fig 2) at a frequency higher than that observed for other antimicrobials (p = 0.0001), followed by oxacillin (35.8%) and erythromycin (32.1%; Table 3). Resistance to sulfamethoxazole-trimethoprim, ciprofloxacin, and rifampicin was higher in the hospitalized cats (Fig 2). Twenty-one isolates (26%) were classified as MDR, and hospitalized animals were almost 4-times more likely to be carriers of MDR Staphylococcus than the non-hospitalized animals (p = 0.039; OR = 3.37; 95% CI: 1.01–11.24; Fig 3). The incidence of MDR was high in S. pseudintermedius (28.6%; p = 0.0032; OR = 11.6; 95% CI: 1.77–123.62), whereas most S. felis strains (65%) were sensitive to all tested antimicrobials.
*Statistical significance at 5% level. Resistant isolates from hospitalized and non-hospitalized cats were compared using Fisher’s exact test. OX, oxacillin; FOX, cefoxitin; P, penicillin; CIP, ciprofloxacin; C, chloramphenicol; DA, clindamycin; E, erythromycin; CN, gentamicin; NIT, nitrofurantoin; RD, rifampicin; STX, sulfamethoxazole-trimethoprim; TE, tetracycline.
Six S. felis isolates were subjected to genomic sequencing. The analysis confirmed the presence of genes resistant to lincosamides (ermA), penicillins (blaZ), streptogramin A (vga(A)), and aminoglycosides (aac(6’)-aph(2”)). However, these genes have not been detected in S. felis genomes analyzed in previous studies (Fig 4) [37, 50–52].
Tree image was generated using iTOL online, with midpoint rooting.
Three isolates detected in this study (GF1-O2, GF17-O, and GF11-O) showed high similarities, with 11–80 SNPs. In SNP analysis, these three isolates, along with two other isolates from this study, were clustered in the same clade (Fig 4). The last isolate from this study was clustered in another clade and grouped with S. felis strains previously isolated from Europe and Asia (Fig 4) [50, 51].
A total of 10.4 and 25% of the non-hospitalized and hospitalized cats, respectively, tested positive on MRS (p = 0.0141). Fifteen isolates (18.5%) were positive for mecA (Table 2). Methicillin resistance was associated with S. pseudintermedius (p = 0.0046; OR = 10.5; 95% CI: 1.66–74.95). Among these, four strains of MRSH (26.7%) were isolated from three hospitalized cats and one domestic cat. In MLST analysis, the MRSH isolates were classified into two STs: ST3 (all isolates from hospitalized cats) and ST8 (all isolates from non-hospitalized cats; Figs 5 and 6).
Red stars indicate the isolates from hospitalized cats (clinical). Blue stars indicate the isolates from non-hospitalized cats (domestic). Triangles indicate the sites at which the isolates were detected, and colored squares indicate the antimicrobial resistance profiles. Tree image was generated using iTOL online, with midpoint rooting.
In section I, sequence types (STs) deposited into the PubMLST database are shown in blue, whereas those detected in this study are shown in red. In section II, clonal complex (CC)-3 was observed, with ST3 being the founder, and ST8 detected after two alleles. Tree image was generated using the PHYLOViZ software 2.0.
Five MRSP isolates were identified in this study from three hospitalized cats. Three isolates (one from each animal) were selected and subjected to WGS analysis. In MLST analysis, two well-known STs were detected: ST551, the founder of CC551, and ST71, the founder of CC71, in one isolate (Figs 7 and 8). MRSP isolates were compared using wgMLST and SNP analyses. Both analyses dismissed the hypothesis of clonality between the two isolates classified as ST551 (1354 SNPs and 281 alleles in wgMLST). However, MRSP ST71 showed similarity with isolates previously detected in Brazil [12, 13] from dogs with MRSP infections, especially with an isolate from a surgical site infection, BR19 (accession number SAMN32679005), which differed by only eight SNPs (Fig 9). Interestingly, the two STs detected in this study (ST551 and ST71) exhibited differences in their resistance genes. Specifically, ST551 harbored tet(M) that confers tetracycline resistance, whereas ST71 harbored tet(K). Additionally, ST71 alone harbored the ant(6)-Ia gene that confers resistance to aminoglycosides (Fig 7). However, both STs shared several resistance genes and point mutations associated with quinolones, rifampicin, lincosamides, and folate pathway antagonists.
Sections I and II show the clusters of STs where ST551 and ST71 were detected. Sections III and IV correspond to CC551 and CC71, respectively. Tree image was generated using the PHYLOViZ software.
Factors associated with MRS colonization
Cats with a history of antimicrobial treatment were almost 21-times more likely to harbor MRS. Hospitalized animals and those with comorbidities, regardless of hospitalization, were almost six- and ten-fold more likely to acquire MRS, respectively (Table 3).
Discussion
Antimicrobial resistance of Staphylococcus spp.
S. felis, the representative Staphylococcus species infecting domestic cats [17, 53], was the most commonly isolated species in this study. Other species found in non-hospitalized cats, such as S. epidermidis, S. aureus, and S. capitis, also colonized the healthy cats, suggesting that these microbes are part of the natural microbiota of cats [17, 54, 55].
To date, only a few studies have genetically evaluated S. felis isolates, with none focused in Brazil. In this study, seven isolates of S. felis from different individuals were subjected to genomic sequencing. Similarity analysis revealed that most isolates were grouped together, indicating a higher degree of similarity among them compared to that among the isolates from other countries. This resemblance also indicates evolution from a common ancestor, accounting for the detection of resistance genes in many Brazilian isolates. These findings are in contrast to previous reports on the absence of these determinants [37, 50, 51]. Therefore, S. felis strains exhibit a distinct epidemiology in Brazil, easily acquiring multidrug resistance genes. However, further studies are necessary to understand the epidemiological characteristics and extent of evolution of such multidrug resistance in Brazilian S. felis strains.
Here, we observed the association between hospitalized cats and isolation of S. pseudintermedius. This finding is important as S. pseudintermedius is a common colonizer of both dogs and cats associated with skin diseases and surgical wounds [12, 13, 56]. Interestingly, S. pseudintermedius isolates were approximately 11-times more likely to be MRS compared to the other Staphylococcus spp., consistent with previous reports [12, 13, 17, 22, 57].
In contrast to the isolates of S. pseudintermedius, S. felis isolates exhibited high sensitivity to most of the tested antimicrobials, with nearly two-thirds of the S. felis isolates being sensitive to all tested compounds. These findings suggest that the use of antimicrobials and hospital environment cause a possible shift in microbiota, decreasing the prevalence of S. felis, which is sensitive to most antibiotics, but increasing that of MRS, especially S. pseudintermedius, consistent with previous reports [17, 22, 58]. This finding was further supported by MRS frequency in hospitalized vs. non-hospitalized cats (25 vs. 10.4%; p = 0.0141).
Molecular characterization of MRSP isolates
Studies evaluating Staphylococcus isolates in cats are scarce, with no study characterizing MRSP isolates in Brazil to date. In this study, one MRSP per animal (n = 3) was selected and subjected to genomic sequencing. Two STs were identified, ST551 (two isolates) and ST71. ST71 is distributed worldwide, shows significant antimicrobial resistance, and mainly infects dogs, occasionally infecting other species, such as cats and humans [12, 22, 59–61]. Similar to previous studies in Brazil, ST71 isolate harbored SCCmec IIIa, which is common among CC71 isolates [13, 62].
The other two isolates were classified as ST551, the founder of CC551. Although less common than the isolates from CC71, CC551 isolates also exhibit resistance to antimicrobials and infection ability [22, 63]. In contrast to the CC71 isolates, CC551 isolates commonly harbor SCCmec Vc (5c1) [11, 64, 65], which is consistent with our findings. Both CC71 and CC551 are distinguished by their high antimicrobial resistance and association with animals in veterinary clinics [11, 13, 22, 62]. Here, both STs harbored genes and specific point mutations conferring resistance to various non-beta-lactam antibiotics, albeit with notable differences, particularly for tetracycline and aminoglycosides. This observation is expected considering the distinct genetic backgrounds of strains from different CCs, which can lead to varying antibiotic resistance profiles [8, 9, 66], including the SCCmec types observed in this study.
As the three MRSP isolates showed the same phenotypic resistance patterns, we hypothesized that they represented the same clone transmitted within the hospital environment, as indicated in previous studies on dogs [10, 13, 67]. Our hypothesis was supported by the fact that the two strains had the same STs and resistance gene patterns. However, our SNPs and wgMLST results rejected this hypothesis, suggesting that the MRSP strains originated from different sources. These findings further confirm the potential of MRSP transmission in clinics, as reported in previous studies [11, 56].
ST71 isolate is similar to other reported MRSP strains in Brazil colonizing and infecting dogs in the same clinical environment (Fig 9) [12, 13, 62]. This indicates the possible transmission of MRSP from dogs to hospitalized cats [10, 13, 68], which is insignificant to the context of this study in cats. Transmission of isolates in veterinary environments primarily occurs during animal handling [12, 13, 22, 69], underscoring the need to re-evaluate the protocols used in veterinary clinics.
Molecular characterization MRSH isolates
In addition to the MRS isolates, other methicillin-resistant species of clinical importance, such as S. haemolyticus, were detected in this study. Isolation of this species from hospitalized cats is associated with transmission during hospital stay. Notably, MRSH is rarely observed in non-hospitalized cats [60, 62] but commonly causes hospital-acquired infections in humans [14, 15, 18, 70–72] and occasionally in hospitalized cats and dogs [16, 17, 19, 73, 74].
The three MRSH isolates identified in this study were subjected to MLST. The isolate from the only non-hospitalized cat that tested positive for MRSH was classified as ST8, an ST previously reported in humans, animals, and hospitals [20, 33, 75, 76]. This cat appeared healthy with no history of antimicrobial use but had outdoor access. In contrast, the isolates from hospitalized cats were classified as ST3, the founder of CC3, which is the main and most widespread CC of MRSH worldwide that commonly infects humans and domestic animals [14, 74, 77]. The three isolates from hospitalized animals receiving antibiotic therapy showed the same phenotypic resistance profiles and were isolated within a short period (within nine days). This highlights the possible spread of MRSH strains among cats in hospitals [74, 78, 79]; further genomic sequencing of the detected isolates is necessary for validation.
Clinical and epidemiological factors associated with MRS and MRSP colonization
In this study, antimicrobial use, comorbidities, and hospitalization were associated with MRS isolation. Several studies have highlighted veterinary hospitalization as a determining factor for MRS infections due to the intensive use of antimicrobials to treat hospitalized animals [2, 12, 13]. This study focused solely on the MRS colonization of animals and did not assess MRSP infection. However, MRSP isolates also exhibit great potential for dissemination and infection, possibly causing hospital outbreaks [10, 13]. Overall, our findings suggest that cats play crucial roles in the dissemination of MRS, including MRSP, and associated infections in clinical settings, highlighting the need for effective surveillance protocols and rational use of antimicrobials in veterinary hospitals and clinics.
References
- 1. Morris DO, Loeffler A, Davis MF, Guardabassi L, Weese JS. Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures.: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Vet Dermatol. 2017;28: 304–e69. pmid:28516494
- 2. Loncaric I, Kübber-Heiss A, Posautz A, Ruppitsch W, Lepuschitz S, Schauer B, et al. Characterization of mecC gene-carrying coagulase-negative Staphylococcus spp. isolated from various animals. Vet Microbiol. 2019;230: 138–144. pmid:30827379
- 3. Weese JS, van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol. 2010;140: 418–429. pmid:19246166
- 4. Andersson DI, Hughes D, Kubicek-Sutherland JZ. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat. 2016;26: 43–57. pmid:27180309
- 5. Morrison L, Zembower TR. Antimicrobial Resistance. Gastrointest Endosc Clin N Am. 2020;30: 619–635. pmid:32891221
- 6. Bünsow D, Tantawy E, Ostermeier T, Bähre H, Garbe A, Larsen J, et al. Methicillin-resistant Staphylococcus pseudintermedius synthesizes deoxyadenosine to cause persistent infection. Virulence. 2021;12: 989–1002. pmid:33779509
- 7. Martínez-Meléndez A, Morfín-Otero R, Villarreal-Treviño L, González-González G, Llaca-Díaz J, Rodríguez-Noriega E, et al. Staphylococcal Cassette Chromosome mec (SCCmec) in coagulase negative staphylococci. Medicina Universitaria. 2015;17: 229–233.
- 8. van Duijkeren E, Catry B, Greko C, Moreno MA, Pomba MC, Pyörälä S, et al. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother. 2011;66: 2705–2714. pmid:21930571
- 9. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17: 203–218. pmid:30737488
- 10. Grönthal T, Eklund M, Thomson K, Piiparinen H, Sironen T, Rantala M. Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland. J Antimicrob Chemother. 2017;72: 1021–1030. pmid:28065889
- 11. Kizerwetter-Świda M, Chrobak-Chmiel D, Rzewuska M, Binek M. Changes in the population structure of canine methicillin-resistant Staphylococcus pseudintermedius in Poland. Veterinary Microbiology. 2017;208: 106–109. pmid:28888624
- 12. Viegas FM, Santana JA, Silva BA, Xavier RGC, Bonisson CT, Câmara JLS, et al. Occurrence and characterization of methicillin-resistant Staphylococcus spp. in diseased dogs in Brazil. PLOS ONE. 2022;17: e0269422. pmid:35657980
- 13. Santana JA, Paraguassu AO, Santana RST, Xavier RGC, Freitas PMC, Aburjaile FF, et al. Risk Factors, Genetic Diversity, and Antimicrobial Resistance of Staphylococcus spp. Isolates in Dogs Admitted to an Intensive Care Unit of a Veterinary Hospital. Antibiotics. 2023;12: 621. pmid:36978487
- 14. Panda S, Jena S, Sharma S, Dhawan B, Nath G, Singh DV. Identification of Novel Sequence Types among Staphylococcus haemolyticus Isolated from Variety of Infections in India. PLOS ONE. 2016;11: e0166193. pmid:27824930
- 15. Szczuka E, Krajewska M, Lijewska D, Bosacka K, Kaznowski A. Diversity of staphylococcal cassette chromosome mec elements in nosocomial multiresistant Staphylococcus haemolyticus isolates. J Appl Genet. 2016;57: 543–547. pmid:27056386
- 16. Ruzauskas M, Siugzdiniene R, Klimiene I, Virgailis M, Mockeliunas R, Vaskeviciute L, et al. Prevalence of methicillin-resistant Staphylococcus haemolyticus in companion animals: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2014;13: 56. pmid:25431281
- 17. Bierowiec K, Korzeniowska-Kowal A, Wzorek A, Rypuła K, Gamian A. Prevalence of Staphylococcus Species Colonization in Healthy and Sick Cats. Biomed Res Int. 2019;2019: 4360525. pmid:30800668
- 18. Yu M-H, Chen Y-G, Yu Y-S, Chen C-L, Li L-J. Antimicrobial resistance and molecular characterization of Staphylococcus haemolyticus in a Chinese hospital. Eur J Clin Microbiol Infect Dis. 2010;29: 613–616. pmid:20204444
- 19. McManus BA, Coleman DC, Deasy EC, Brennan GI, Connell BO, Monecke S, et al. Comparative Genotypes, Staphylococcal Cassette Chromosome mec (SCCmec) Genes and Antimicrobial Resistance amongst Staphylococcus epidermidis and Staphylococcus haemolyticus Isolates from Infections in Humans and Companion Animals. PLOS ONE. 2015;10: e0138079. pmid:26379051
- 20. Kornienko M, Ilina E, Lubasovskaya L, Priputnevich T, Falova O, Sukhikh G, et al. Analysis of nosocomial Staphylococcus haemolyticus by MLST and MALDI-TOF mass spectrometry. Infection, Genetics and Evolution. 2016;39: 99–105. pmid:26723920
- 21. Quitoco IMZ, Ramundo MS, Silva-Carvalho MC, Souza RR, Beltrame CO, de Oliveira TF, et al. First report in South America of companion animal colonization by the USA1100 clone of community-acquired meticillin-resistant Staphylococcus aureus (ST30) and by the European clone of methicillin-resistant Staphylococcus pseudintermedius (ST71). BMC Res Notes. 2013;6: 336. pmid:23981343
- 22. Bierowiec K, Miszczak M, Korzeniowska-Kowal A, Wzorek A, Płókarz D, Gamian A. Epidemiology of Staphylococcus pseudintermedius in cats in Poland. Sci Rep. 2021;11: 18898. pmid:34556720
- 23. Rana EA, Nizami TA, Islam MS, Sarker S, Rahman H, Hoque A, et al. Antimicrobial resistance and virulence profiling of Staphylococcus pseudintermedius isolated from cats, Bangladesh. Vet Q. 2024;44: 1–11. pmid:38487883
- 24. Elnageh HR, Hiblu MA, Abbassi MS, Abouzeed YM, Ahmed MO. Prevalence and antimicrobial resistance of Staphylococcus species isolated from cats and dogs. Open Vet J. 2021;10: 452–456. pmid:33614441
- 25. Assis GBN, Pereira FL, Zegarra AU, Tavares GC, Leal CA, Figueiredo HCP. Use of MALDI-TOF Mass Spectrometry for the Fast Identification of Gram-Positive Fish Pathogens. Front Microbiol. 2017;8: 1492. pmid:28848512
- 26. Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, et al. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol. 1995;33: 445–454.
- 27. Mellmann A, Becker K, von Eiff C, Keckevoet U, Schumann P, Harmsen D. Sequencing and staphylococci identification. Emerg Infect Dis. 2006;12: 333–336. pmid:16494767
- 28. Sasaki T, Tsubakishita S, Tanaka Y, Sakusabe A, Ohtsuka M, Hirotaki S, et al. Multiplex-PCR method for species identification of coagulase-positive staphylococci. J Clin Microbiol. 2010;48: 765–769. pmid:20053855
- 29.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100 (ISBN 978-1-68440-104-8 [Print]; ISBN 978-1-68440-105-5 [Electronic]). Clinical and Laboratory Standards Institute, USA, 2021.
- 30. Sweeney MT, Lubbers BV, Schwarz S, Watts JL. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens. J Antimicrob Chemother. 2018;73: 1460–1463. pmid:29481657
- 31. Pitcher D g., Saunders N a., Owen R j. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Letters in Applied Microbiology. 1989;8: 151–156.
- 32. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol. 1991;29: 2240–2244. pmid:1939577
- 33. Cavanagh JP, Klingenberg C, Hanssen A-M, Fredheim EA, Francois P, Schrenzel J, et al. Core genome conservation of Staphylococcus haemolyticus limits sequence based population structure analysis. Journal of Microbiological Methods. 2012;89: 159–166. pmid:22484086
- 34. Francisco AP, Bugalho M, Ramirez M, Carriço JA. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics. 2009;10: 152. pmid:19450271
- 35. Nascimento M, Sousa A, Ramirez M, Francisco AP, Carriço JA, Vaz C. PHYLOViZ 2.0: providing scalable data integration and visualization for multiple phylogenetic inference methods. Bioinformatics. 2017;33: 128–129. pmid:27605102
- 36. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49: W293–W296. pmid:33885785
- 37. Worthing K, Pang S, Trott DJ, Abraham S, Coombs GW, Jordan D, et al. Characterisation of Staphylococcus felis isolated from cats using whole genome sequencing. Vet Microbiol. 2018;222: 98–104. pmid:30080680
- 38. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19: 455–477. pmid:22506599
- 39. Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, et al. Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement. PLOS ONE. 2014;9: e112963. pmid:25409509
- 40. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10: 421. pmid:20003500
- 41. Clausen PTLC, Aarestrup FM, Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics. 2018;19: 307. pmid:30157759
- 42. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. Journal of Antimicrobial Chemotherapy. 2020;75: 3491–3500. pmid:32780112
- 43. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing. Antimicrobial Agents and Chemotherapy. 2014;58: 3895–3903. pmid:24777092
- 44. Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. Journal of Antimicrobial Chemotherapy. 2017;72: 2764–2768. pmid:29091202
- 45. Kondo Y, Ito T, Ma XX, Watanabe S, Kreiswirth BN, Etienne J, et al. Combination of Multiplex PCRs for Staphylococcal Cassette Chromosome mec Type Assignment: Rapid Identification System for mec, ccr, and Major Differences in Junkyard Regions. Antimicrobial Agents and Chemotherapy. 2007;51: 264–274. pmid:17043114
- 46. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria. Journal of Clinical Microbiology. 2020;50: 1355–1361. pmid:22238442
- 47.
Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv; 2013.
- 48. Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. Solving the Problem of Comparing Whole Bacterial Genomes across Different Sequencing Platforms. PLOS ONE. 2014;9: e104984. pmid:25110940
- 49. Liu Y-Y, Lin J-W, Chen C-C. cano-wgMLST_BacCompare: A Bacterial Genome Analysis Platform for Epidemiological Investigation and Comparative Genomic Analysis. Frontiers in Microbiology. 2019;10. Available: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.01687 pmid:31396192
- 50. Aslantaş Ö, Keskin O, Büyükaltay K, Yücetepe AG. Draft Genome Sequence of Staphylococcus felis HARRANVET Strain. MAEU Vet Fak Derg. 2021;6: 78–81.
- 51. Sips GJ, van Dijk MAM, van Westreenen M, van der Graaf-van Bloois L, Duim B, Broens EM. Evidence of cat-to-human transmission of Staphylococcus felis. J Med Microbiol. 2023;72. pmid:36763079
- 52. Sichtig H, Minogue T, Yan Y, Stefan C, Hall A, Tallon L, et al. FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science. Nat Commun. 2019;10: 3313. pmid:31346170
- 53. Older CE, Diesel AB, Starks JM, Lawhon SD, Rodrigues Hoffmann A. Characterization of staphylococcal communities on healthy and allergic feline skin. Vet Dermatol. 2021;32: 61–e10. pmid:32991044
- 54. Abdullahi IN, Zarazaga M, Campaña-Burguet A, Eguizábal P, Lozano C, Torres C. Nasal Staphylococcus aureus and S. pseudintermedius carriage in healthy dogs and cats: a systematic review of their antibiotic resistance, virulence and genetic lineages of zoonotic relevance. J Appl Microbiol. 2022;133: 3368–3390. pmid:36063061
- 55. Cheung KT, Chan HY. Oral flora of domestic cats in Hong Kong: Identification of antibiotic-resistant strains. Vet Med Sci. 2022. pmid:36520663
- 56. Fàbregas N, Pérez D, Viñes J, Cuscó A, Migura-García L, Ferrer L, et al. Diverse Populations of Staphylococcus pseudintermedius Colonize the Skin of Healthy Dogs. Microbiol Spectr. 2023;11: e0339322. pmid:36786649
- 57. Maksimović Z, Dizdarević J, Babić S, Rifatbegović M. Antimicrobial Resistance in Coagulase-Positive Staphylococci Isolated from Various Animals in Bosnia and Herzegovina. Microb Drug Resist. 2022;28: 136–142. pmid:34860586
- 58. Lehner G, Linek M, Bond R, Lloyd DH, Prenger-Berninghoff E, Thom N, et al. Case-control risk factor study of methicillin-resistant Staphylococcus pseudintermedius (MRSP) infection in dogs and cats in Germany. Vet Microbiol. 2014;168: 154–160. pmid:24290489
- 59. Lozano C, Rezusta A, Ferrer I, Pérez-Laguna V, Zarazaga M, Ruiz-Ripa L, et al. Staphylococcus pseudintermedius Human Infection Cases in Spain: Dog-to-Human Transmission. Vector Borne Zoonotic Dis. 2017;17: 268–270. pmid:28075235
- 60. Kitagawa H, Hisatsune J, Ohge H, Kutsuno S, Hara T, Masuda K, et al. Implanted Port Catheter System Infection Caused by Methicillin-resistant Staphylococcus pseudintermedius ST71-SCCmec type III. Intern Med. 2021;60: 2337–2340. pmid:33583884
- 61. Moses IB, Santos FF, Gales AC. Human Colonization and Infection by Staphylococcus pseudintermedius: An Emerging and Underestimated Zoonotic Pathogen. Microorganisms. 2023;11: 581. pmid:36985155
- 62. Teixeira IM, de Moraes Assumpção Y, Paletta ACC, Aguiar L, Guimarães L, da Silva IT, et al. Investigation of antimicrobial susceptibility and genetic diversity among Staphylococcus pseudintermedius isolated from dogs in Rio de Janeiro. Sci Rep. 2023;13: 20219. pmid:37980395
- 63. Vitali LA, Beghelli D, Balducci M, Petrelli D. Draft genome of an extremely drug-resistant ST551 Staphylococcus pseudintermedius from an Italian dog with otitis externa. Journal of Global Antimicrobial Resistance. 2021;25: 107–109. pmid:33662646
- 64. Uehara Y. Current Status of Staphylococcal Cassette Chromosome mec (SCCmec). Antibiotics (Basel). 2022;11: 86. pmid:35052963
- 65. Takahashi T, Kim H, Kim H-S, Kim HS, Song W, Kim J-S. Comparative Genomic Analysis of Staphylococcal Cassette Chromosome mec Type V Staphylococcus aureus Strains and Estimation of the Emergence of SCCmec V Clinical Isolates in Korea. Ann Lab Med. 2024;44: 47–55. pmid:37665285
- 66. Srednik ME, Perea CA, Giacoboni GI, Hicks JA, Foxx CL, Harris B, et al. Genomic Features of Antimicrobial Resistance in Staphylococcus pseudintermedius Isolated from Dogs with Pyoderma in Argentina and the United States: A Comparative Study. Int J Mol Sci. 2023;24: 11361. pmid:37511121
- 67. Papić B, Golob M, Zdovc I, Kušar D, Avberšek J. Genomic insights into the emergence and spread of methicillin-resistant Staphylococcus pseudintermedius in veterinary clinics. Vet Microbiol. 2021;258: 109119. pmid:34023637
- 68. Worthing KA, Brown J, Gerber L, Trott DJ, Abraham S, Norris JM. Methicillin-resistant staphylococci amongst veterinary personnel, personnel-owned pets, patients and the hospital environment of two small animal veterinary hospitals. Vet Microbiol. 2018;223: 79–85. pmid:30173756
- 69. Soimala T, Lübke-Becker A, Hanke D, Eichhorn I, Feßler AT, Schwarz S, et al. Molecular and phenotypic characterization of methicillin-resistant Staphylococcus pseudintermedius from ocular surfaces of dogs and cats suffering from ophthalmological diseases. Vet Microbiol. 2020;244: 108687. pmid:32402352
- 70. Hosseinkhani F, Tammes Buirs M, Jabalameli F, Emaneini M, van Leeuwen WB. High diversity in SCCmec elements among multidrug-resistant Staphylococcus haemolyticus strains originating from paediatric patients; characterization of a new composite island. J Med Microbiol. 2018;67: 915–921. pmid:29873628
- 71. Maleki A, Ghafourian S, Taherikalani M, Soroush S. Alarming and Threatening Signals from Health Centers About Multi Drug Resistance Staphylococcus haemolyticus. Infect Disord Drug Targets. 2019;19: 118–127. pmid:30207248
- 72. Westberg R, Stegger M, Söderquist B. Molecular Epidemiology of Neonatal-Associated Staphylococcus haemolyticus Reveals Endemic Outbreak. Microbiol Spectr. 2022; e0245222. pmid:36314976
- 73. Kizerwetter-Świda M, Chrobak-Chmiel D, Kwiecień E, Rzewuska M, Binek M. Molecular characterization of high-level mupirocin resistance in methicillin-resistant staphylococci isolated from companion animals. Vet Microbiol. 2021;259: 109160. pmid:34197979
- 74. Citron LE, Cain CL, Dietrich J, Cole SD. Genomic and clinical case characterisation of Staphylococcus haemolyticus isolated from dogs and cats in the United States, including strains with high-level mupirocin tolerance. Vet Dermatol. 2023;34: 298–309. pmid:36908239
- 75. Weiss S, Kadlec K, Fessler AT, Schwarz S. Identification and characterization of methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus pettenkoferi from a small animal clinic. Vet Microbiol. 2013;167: 680–685. pmid:23992797
- 76. Montelongo C, Mores CR, Putonti C, Wolfe AJ, Abouelfetouh A. Whole-Genome Sequencing of Staphylococcus aureus and Staphylococcus haemolyticus Clinical Isolates from Egypt. Microbiol Spectr. 2022;10: e0241321. pmid:35727037
- 77. Morgado S, Freitas F, Caldart R, Fonseca E, Vicente AC. In-silico genomic characterization of Staphylococcus haemolyticus on a global scale: strains, resistome and virulome. Journal of Infection and Public Health. 2024;17: 18–24.
- 78. Bouchami O, de Lencastre H, Miragaia M. Impact of Insertion Sequences and Recombination on the Population Structure of Staphylococcus haemolyticus. PLOS ONE. 2016;11: e0156653. pmid:27249649
- 79. Bean DC, Wigmore SM, Wareham DW. Draft Genome Sequence of a Canine Isolate of Methicillin-Resistant Staphylococcus haemolyticus. Genome Announcements. 2017;5: pmid:28385855